These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32973954)

  • 1. ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
    Sun R; Yang L; Hu Y; Wang Y; Zhang Q; Zhang Y; Ji Z; Zhao D
    Oncol Lett; 2020 Nov; 20(5):240. PubMed ID: 32973954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138.
    Chen H; Xiao Q; Hu Y; Chen L; Jiang K; Tang Y; Tan Y; Hu W; Wang Z; He J; Liu Y; Cai Y; Yang Q; Ding K
    J Exp Clin Cancer Res; 2017 Jun; 36(1):78. PubMed ID: 28606130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress Slug expression.
    Fan H; Huang L; Zhuang X; Ai F; Sun W
    Cytotechnology; 2019 Feb; 71(1):35-44. PubMed ID: 30610511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer.
    Meng Z; Tan J; Zhang G; Tian W; Fu Q; Li W; He X; Wu S; Yang Z; Liang X; Dong L; Zhang Q; Liu L; Zhang Y; Xu K; Liu B; Li N; Li X; Jia Q; He Y; Wang S; Wang R; Zheng W; Song X; Zhang J; Hu T; Liu N; Upadhyaya A
    Life Sci; 2015 Jun; 130():18-24. PubMed ID: 25817231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.
    Chen HA; Kuo TC; Tseng CF; Ma JT; Yang ST; Yen CJ; Yang CY; Sung SY; Su JL
    Hepatology; 2016 Nov; 64(5):1637-1651. PubMed ID: 27530187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer.
    Li C; Peng X; Lv J; Zou H; Liu J; Zhang K; Li Z
    Biomed Pharmacother; 2020 Mar; 123():109791. PubMed ID: 31887541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.
    Yu XM; Jaskula-Sztul R; Georgen MR; Aburjania Z; Somnay YR; Leverson G; Sippel RS; Lloyd RV; Johnson BP; Chen H
    Clin Cancer Res; 2016 Jul; 22(14):3582-92. PubMed ID: 26847059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs lnc-ANGPTL1-3:3 and lnc-GJA10-12:1 present as regulators of sentinel lymph node metastasis in breast cancer.
    Sun D; Zhong J; Wei W; Liu L; Liu J; Lin X
    Oncol Lett; 2020 Nov; 20(5):188. PubMed ID: 32952657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma.
    Wu M; Wei B; Duan SL; Liu M; Ou-Yang DJ; Huang P; Chang S
    Front Cell Dev Biol; 2022; 10():819484. PubMed ID: 35141223
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
    Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
    Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
    Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
    Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis.
    Jiang K; Chen H; Ding K
    Clin Sci (Lond); 2022 Sep; 136(18):1367-1370. PubMed ID: 36156125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer.
    Shankar J; Wiseman SM; Meng F; Kasaian K; Strugnell S; Mofid A; Gown A; Jones SJ; Nabi IR
    J Pathol; 2012 Sep; 228(1):56-66. PubMed ID: 22513979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of Interleukin-12A and Its Association with the Clinicopathology and Prognosis of Differentiated Thyroid Cancer.
    Zhang GQ; Shen CT; Song HJ; Qiu ZL; Luo QY
    Eur Thyroid J; 2020 May; 9(3):139-147. PubMed ID: 32523890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma.
    Tong J; Jiang W; Zhang X; Wang R; Qiao T; Song Y; Gao D; Yu X; Lv Z; Li D
    J Int Med Res; 2022 Dec; 50(12):3000605221139555. PubMed ID: 36495170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
    Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
    Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.
    Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z
    Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.